Medlive Technology Co., Ltd.

SEHK:2192 Rapport sur les actions

Capitalisation boursière : HK$5.9b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Medlive Technology Gestion

Gestion contrôle des critères 2/4

Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.

Informations clés

Liping Tian

Directeur général

CN¥4.8m

Rémunération totale

Pourcentage du salaire du PDG35.8%
Durée du mandat du directeur général11.3yrs
Propriété du PDG1.1%
Durée moyenne d'occupation des postes de directionpas de données
Durée moyenne du mandat des membres du conseil d'administration6.1yrs

Mises à jour récentes de la gestion

Recent updates

Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital

Jul 04
Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital

Medlive Technology Co., Ltd.'s (HKG:2192) Business Is Yet to Catch Up With Its Share Price

Apr 08
Medlive Technology Co., Ltd.'s (HKG:2192) Business Is Yet to Catch Up With Its Share Price

Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return

Feb 20
Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return

Are Medlive Technology Co., Ltd. (HKG:2192) Investors Paying Above The Intrinsic Value?

Jan 10
Are Medlive Technology Co., Ltd. (HKG:2192) Investors Paying Above The Intrinsic Value?

Medlive Technology Co., Ltd.'s (HKG:2192) Intrinsic Value Is Potentially 20% Below Its Share Price

Sep 27
Medlive Technology Co., Ltd.'s (HKG:2192) Intrinsic Value Is Potentially 20% Below Its Share Price

Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return

Jul 10
Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return

Medlive Technology Co., Ltd. (HKG:2192) Shares Slammed 28% But Getting In Cheap Might Be Difficult Regardless

May 11
Medlive Technology Co., Ltd. (HKG:2192) Shares Slammed 28% But Getting In Cheap Might Be Difficult Regardless

Robust Earnings May Not Tell The Whole Story For Medlive Technology (HKG:2192)

May 02
Robust Earnings May Not Tell The Whole Story For Medlive Technology (HKG:2192)

Results: Medlive Technology Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Mar 26
Results: Medlive Technology Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Here's What's Concerning About Medlive Technology's (HKG:2192) Returns On Capital

Feb 06
Here's What's Concerning About Medlive Technology's (HKG:2192) Returns On Capital

There Are Reasons To Feel Uneasy About Medlive Technology's (HKG:2192) Returns On Capital

Oct 31
There Are Reasons To Feel Uneasy About Medlive Technology's (HKG:2192) Returns On Capital

Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital

Jul 14
Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital

These Analysts Just Made A Massive Downgrade To Their Medlive Technology Co., Ltd. (HKG:2192) EPS Forecasts

Apr 03
These Analysts Just Made A Massive Downgrade To Their Medlive Technology Co., Ltd. (HKG:2192) EPS Forecasts

Is Medlive Technology Co., Ltd. (HKG:2192) Worth HK$9.5 Based On Its Intrinsic Value?

Feb 22
Is Medlive Technology Co., Ltd. (HKG:2192) Worth HK$9.5 Based On Its Intrinsic Value?

Analyse de la rémunération des PDG

Comment la rémunération de Liping Tian a-t-elle évolué par rapport aux bénéfices de Medlive Technology?
DateRémunération totaleSalaireBénéfices de l'entreprise
Jun 30 2024n/an/a

CN¥290m

Mar 31 2024n/an/a

CN¥266m

Dec 31 2023CN¥5mCN¥2m

CN¥242m

Sep 30 2023n/an/a

CN¥216m

Jun 30 2023n/an/a

CN¥189m

Mar 31 2023n/an/a

CN¥153m

Dec 31 2022CN¥7mCN¥2m

CN¥117m

Sep 30 2022n/an/a

CN¥83m

Jun 30 2022n/an/a

CN¥48m

Mar 31 2022n/an/a

CN¥44m

Dec 31 2021CN¥7mCN¥1m

CN¥41m

Sep 30 2021n/an/a

CN¥55m

Jun 30 2021n/an/a

CN¥70m

Mar 31 2021n/an/a

CN¥78m

Dec 31 2020CN¥816kCN¥816k

CN¥85m

Dec 31 2019CN¥756kCN¥756k

CN¥31m

Dec 31 2018CN¥736kCN¥736k

CN¥14m

Rémunération vs marché: La rémunération totale de Liping ($USD 678.35K ) est supérieure à la moyenne des entreprises de taille similaire sur le marché Hong Kong ($USD 472.69K ).

Rémunération et revenus: La rémunération de Liping a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.


PDG

Liping Tian (57 yo)

11.3yrs

Titularisation

CN¥4,839,000

Compensation

Ms. Liping Tian is Chairwoman and Chief Executive Officer of Medlive Technology Co. Ltd. Ms. Tian has been Executive Director of Medlive Technology Co. Ltd since April 2013. She has been the executive dire...


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Liping Tian
Chairwoman & CEO11.3yrsCN¥4.84m1.1%
CN¥ 65.0m
Lixin Tian
President10.7yrsCN¥2.14m0.27%
CN¥ 16.1m
Lijun Tian
VP, Deputy Head of Medical Information Science Research Unit & Executive Director10.7yrsCN¥2.04m0.21%
CN¥ 12.6m
Xin Zhou
VP & Executive Director6.1yrsCN¥673.00kpas de données
Richard L. Yeh
Independent Non-Executive Director3.6yrsCN¥120.00kpas de données
Eiji Tsuchiya
Non-Executive Director10.7yrspas de donnéespas de données
Jun Ma
Independent Non-Executive Director3.6yrsCN¥120.00kpas de données
Shan Wang
Independent Non-Executive Director3.6yrsCN¥120.00kpas de données
Kazutaka Kanairo
Non-Executive Director1.3yrspas de donnéespas de données

6.1yrs

Durée moyenne de l'emploi

55yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de 2192 sont considérés comme expérimentés (ancienneté moyenne 6.1 ans).